Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Summary of Meeting Proceedings on Addressing Variability around the Cut Point in Serial Interferon-gamma Release Assay Testing INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY Daley, C. L., Reves, R. R., Beard, M. A., Boyle, J., Clark, R. B., Beebe, J. L., Catanzaro, A., Chen, L., Desmond, E., Dorman, S. E., Hudson, T. W., Lardizabal, A. A., Kapoor, H., Marder, D. C., Miranda, C., Narita, M., Reichman, L., Schwab, D., Seaworth, B. J., Terpeluk, P., Thanassi, W., Kawamura, L. M. 2013; 34 (6): 625-630

Abstract

On June 13, 2012, a group of key stakeholders, leaders, and national experts on tuberculosis (TB), occupational health, and laboratory science met in Atlanta, Georgia, to focus national discussion on the higher than expected positive results occurring among low-risk, unexposed healthcare workers undergoing serial testing with interferon-? release assays (IGRAs). The objectives of the meeting were to present the latest clinical and operational research findings on the topic, to discuss evaluation and treatment algorithms that are emerging in the absence of national guidance, and to develop a consensus on the action steps needed to assist programs and physicians in the interpretation of serial testing IGRA results. This report summarizes its proceedings.

View details for DOI 10.1086/670635

View details for Web of Science ID 000318766800013

View details for PubMedID 23651895